Fig. 4From: Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cellsDose response and time response curves of MCF-7 and HEpG2 cells treated with 6-gingerol, doxorubicin and 6-Gin + Dox-m-HAP. a–c Effect of these systems on MCF-7 cells over 24, 48 and 72 h. d–f Effect of these systems on HEpG2 cells over 24, 48 and 72 h. Results are given as mean ± SD, n = 3Back to article page